Letters High reprint orders

Income from reprints creates a conflict of interests

BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e4970 (Published 23 July 2012) Cite this as: BMJ 2012;345:e4970
  1. Andreas Lundh, PhD student1,
  2. Asbjørn Hróbjartsson, senior researcher1,
  3. Peter C Gøtzsche, professor and director1
  1. 1Nordic Cochrane Centre, Rigshospitalet, 2100 Copenhagen, Denmark
  1. al{at}cochrane.dk

Although the BMJ and Lancet provided Handel and colleagues access to information on reprint sales,1 the big US journals were unwilling to share this information. Our experience was similar when we investigated reprint sales.2

Much of the previous evidence in this field has been anecdotal, such as the infamous VIGOR trial of rofecoxib, where …

View Full Text

Log in

Log in through your institution


* For online subscription